| Literature DB >> 29250704 |
Mathieu Tardat1, Jérôme Déjardin2.
Abstract
Telomeres are specialized structures that evolved to protect the end of linear chromosomes from the action of the cell DNA damage machinery. They are composed of tandem arrays of repeated DNA sequences with a specific heterochromatic organization. The length of telomeric repeats is dynamically regulated and can be affected by changes in the telomere chromatin structure. When telomeres are not properly controlled, the resulting chromosomal alterations can induce genomic instability and ultimately the development of human diseases, such as cancer. Therefore, proper establishment, regulation, and maintenance of the telomere chromatin structure are required for cell homeostasis. Here, we review the current knowledge on telomeric chromatin dynamics during cell division and early development in mammals, and how its proper regulation safeguards genome stability.Entities:
Keywords: Chromatin; Development; Genome stability; Telomere
Mesh:
Substances:
Year: 2017 PMID: 29250704 PMCID: PMC5818603 DOI: 10.1007/s00412-017-0656-3
Source DB: PubMed Journal: Chromosoma ISSN: 0009-5915 Impact factor: 4.316
Fig. 1Chromatin structure of human and mouse telomeres. Telomeric chromatin is organized in a closed state with repressive histone posttranslational modifications (PTM), similar to those observed at pericentric heterochromatin (PCH) domains. Telomeric nucleosomes are labeled with H3K9me3 and possibly H4K20me3, while subtelomeric DNA is also methylated at CpG dinucleotides. H3.3-containing nucleosomes are provided by the ATRX/DAXX complex. Although telomeric chromatin is heterochromatic, subtelomeric regions contain promoters that promote the transcription of the long non-coding RNA TERRA. Telomere length is maintained by the action of the enzyme telomerase that catalyzes the addition of extra TTAGGG repeats to chromosome ends. Shelterin complexes bind along the telomere and protect from recognition by the DNA damage pathway. For graphical clarity, only one shelterin complex (TRF1, TRF2, POT1a/b, TPP1, and TIN2) is shown (top). In a subset of cancer cells, telomerase is not used to elongate telomeres. Instead, alternative lengthening of telomere (or ALT), allows recombination-mediated elongation. ATRX is frequently lost in ALT cells. Repressive marks are reduced, and TERRA RNA is more abundant, leading to putative recombinogenic DNA-RNA hybrids (R-loops). Variant repeats in ALT cells can induce binding of NR2C/F transcription factors to telomeres, leading to chromosomal rearrangements and genomic instability (bottom)
Fig. 2Telomere dynamics during mouse embryo preimplantation development. Extensive chromatin remodeling occurs at the onset of embryo development, with a histone-to-protamine replacement after fertilization, formation of the two parental pronuclei and major zygotic genome activation (ZGA) at the two-cell stage. In this environment, telomeres are elongated by a recombination-mediated mechanism that is telomerase-independent at the one- and two-cell stage. It is not known whether this mechanism is also used at later stages. Then, telomerase activity is readily detected starting from the morula-blastocyst transition. In mouse zygotes, ATRX labels PCH, and by the morula stage, ATRX is clearly targeted to telomeres. Telomere chromatin maturation might allow ATRX targeting by yet unknown mechanisms, such as recognition of histone PTM, a specific chromatin factor or binding to TERRA that is expressed at the 4-cell stage (TERRA dynamics at later stages are still unclear). DUX, a major driver of ZGA in both mouse and human zygotes, promotes expression of endogenous retroviruses (MERVL), H3K9 lysine demethylases from the Kdm4 family and Zscan4 that favors telomere elongation by recombination in mouse ES cells